President Trump considers imposing retaliatory economic sanctions on Chinese products.

Peter Prince

2018-01-10 08:40:00 Wed ET

President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement of U.S. intellectual property. Trump's retaliatory trade sanctions may involve tariffs, quotas, embargoes, and other restrictions on China's investments in U.S. companies. This punitive penalty arises as part of a recent Trade Act Section 301 probe into China's recent regulations that induce U.S. multinational corporations to establish onshore IT data centers. These regulations force unfair intellectual property and technology transfer from these U.S. multinational corporations to their Chinese counterparts. Without such technology transfer, the use and implementation of U.S. patents and trademarks would otherwise involve egregious infringement at the expense of U.S. firms and other innovators.

Recent empirical evidence suggests that this unfair technology transfer may be the root cause of both billions of dollar losses in corporate revenue as well as millions of job losses in America. In addition to intellectual property theft and infringement, the Trump administration also accuses China of currency manipulation. Over the years, China has been accumulating substantial dollar reserves in the form of U.S. Treasury bonds for better renminbi devaluation. This deliberate devaluation leads to more competitive Chinese export prices and thus better low-cost product sales abroad. The Trump administration needs to consider retaliatory trade sanctions on China in order to eradicate trade deficits with better fiscal discipline.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits.

Joseph Corr

2019-05-23 10:33:00 Thursday ET

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits.

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits. French econo

+See More

Capital structure theory and practice

Jonah Whanau

2022-03-15 10:32:00 Tuesday ET

Capital structure theory and practice

Capital structure theory and practice  The genesis of modern capital structure theory traces back to the seminal work of Modigliani and Miller (1958

+See More

American China-specialists champion the key notion of *strategic engagement* with the Xi administration.

James Campbell

2018-12-11 10:34:06 Tuesday ET

American China-specialists champion the key notion of *strategic engagement* with the Xi administration.

Several eminent American China-specialists champion the key notion of *strategic engagement* with the Xi administration. From the Hoover Institution at Stan

+See More

Income and wealth concentration follows the ebbs and flows of the business cycle in America.

Amy Hamilton

2019-04-23 19:45:00 Tuesday ET

Income and wealth concentration follows the ebbs and flows of the business cycle in America.

Income and wealth concentration follows the ebbs and flows of the business cycle in America. Economic inequality not only grows among people, but it also gr

+See More

President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports.

Peter Prince

2019-02-15 11:33:00 Friday ET

President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports.

President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports if both sides are close to mutual agreement. These bilat

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More